Puregon



Indications and Reactions:

Role Indications Reactions
Primary
Ovulation Induction 21.8%
In Vitro Fertilisation 19.0%
Infertility 12.7%
Product Used For Unknown Indication 9.9%
Assisted Fertilisation 8.5%
Anovulatory Cycle 7.0%
Infertility Male 7.0%
Infertility Female 3.5%
Oocyte Donation 3.5%
Ovarian Hyperstimulation Syndrome 2.1%
Blood Luteinising Hormone 1.4%
Ovarian Disorder 1.4%
Endometriosis 0.7%
Luteal Phase Deficiency 0.7%
Ovulation Disorder 0.7%
Ovarian Hyperstimulation Syndrome 40.7%
Deep Vein Thrombosis 5.6%
Ectopic Pregnancy 5.6%
Exposure During Pregnancy 5.6%
Maternal Exposure During Pregnancy 5.6%
Anaphylactic Reaction 3.7%
Drug Exposure During Pregnancy 3.7%
Non-hodgkin's Lymphoma 3.7%
Ovarian Torsion 3.7%
Pleural Effusion 3.7%
Abdominal Cavity Drainage 1.9%
Abortion Spontaneous 1.9%
Acute Generalised Exanthematous Pustulosis 1.9%
Cerebral Venous Thrombosis 1.9%
Foetal Exposure During Pregnancy 1.9%
Injection Site Pain 1.9%
Irritability 1.9%
Ovarian Enlargement 1.9%
Overdose 1.9%
Pain 1.9%
Secondary
In Vitro Fertilisation 31.3%
Ovulation Induction 22.5%
Product Used For Unknown Indication 13.0%
Infertility 6.0%
Assisted Fertilisation 4.7%
Ovarian Hyperstimulation Syndrome 3.5%
Anovulatory Cycle 3.2%
Infertility Male 3.2%
Gamete Intrafallopian Transfer 2.5%
Ill-defined Disorder 1.9%
Oocyte Donation 1.6%
Blood Luteinising Hormone 1.3%
Artificial Insemination By Partner 0.9%
Drug Therapy 0.9%
Hormone Therapy 0.9%
Prophylaxis 0.9%
Vitamin Supplementation 0.6%
Infertility Female 0.3%
Luteal Phase Deficiency 0.3%
Ovarian Disorder 0.3%
Ovarian Hyperstimulation Syndrome 33.3%
Exposure During Pregnancy 9.0%
Maternal Exposure During Pregnancy 7.7%
Deep Vein Thrombosis 6.4%
Invasive Ductal Breast Carcinoma 5.1%
Ascites 3.8%
Pelvic Fluid Collection 3.8%
Transient Ischaemic Attack 3.8%
Breast Cancer 2.6%
Drug Exposure During Pregnancy 2.6%
Ectopic Pregnancy 2.6%
Foetal Growth Restriction 2.6%
Pain In Extremity 2.6%
Pancreatitis Acute 2.6%
Pulmonary Embolism 2.6%
Thyroiditis 2.6%
Uterine Haemorrhage 2.6%
Acute Generalised Exanthematous Pustulosis 1.3%
Cerebral Infarction 1.3%
Cholestasis Of Pregnancy 1.3%
Concomitant
Product Used For Unknown Indication 21.5%
Ovulation Induction 15.2%
Blood Follicle Stimulating Hormone Decreased 10.1%
Blood Luteinising Hormone Decreased 10.1%
In Vitro Fertilisation 7.6%
Crohn's Disease 6.3%
Assisted Fertilisation 5.1%
Infertility Female 5.1%
Infertility 3.8%
Bipolar Disorder 2.5%
Oocyte Donation 2.5%
Abortion Threatened 1.3%
Endometriosis 1.3%
Hypothyroidism 1.3%
Infertility Male 1.3%
Labour Induction 1.3%
Prophylaxis Of Neural Tube Defect 1.3%
Thrombosis Prophylaxis 1.3%
Vulvovaginal Mycotic Infection 1.3%
Transverse Presentation 12.5%
Drug Exposure During Pregnancy 8.3%
Drug Ineffective 8.3%
Epilepsy 8.3%
Hot Flush 8.3%
Pain 8.3%
Anaphylactic Reaction 4.2%
Depression 4.2%
Erythema 4.2%
Intra-uterine Death 4.2%
Leukocytoclastic Vasculitis 4.2%
Low Density Lipoprotein Increased 4.2%
Malaise 4.2%
Renal Dysplasia 4.2%
Suicidal Ideation 4.2%
Thrombocytopenia Neonatal 4.2%
Trisomy 18 4.2%
Interacting
In Vitro Fertilisation 100.0%
Ovarian Hyperstimulation Syndrome 100.0%